Literature DB >> 18230641

Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies.

Gabriel J Arismendi-Morillo1, Alan V Castellano-Ramirez.   

Abstract

This study was realized to illustrate and analyze the ultrastructural mitochondrial pathology in human astrocytic tumors. Tumoral biopsies of 10 patients with pathological diagnosis of astrocytic tumors by means of transmission electron microscopy were examined. Mitochondria exhibits heterogeneous morphology in all the cases. Mitochondrial swelling with partial or total cristolysis was the most constant alteration observed. Mitochondrial fusion-fission phenomena have been demonstrated. These findings suggest that the majority of astrocytoma cells are incompetent to produce adequate amount of energy by means of oxidative phosphorylation. Ultrastructural mitochondrial pathology indicates that possibly both glycolytic inhibition and inhibition or down-regulation of mitochondrial respiration would be a potential tool for future therapeutic strategies in cases of human astrocytic tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18230641     DOI: 10.1093/jmicro/dfm038

Source DB:  PubMed          Journal:  J Electron Microsc (Tokyo)        ISSN: 0022-0744


  26 in total

Review 1.  Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.

Authors:  Lisheng Ge; Neil T Hoa; Zechariah Wilson; Gabriel Arismendi-Morillo; Xiao-Tang Kong; Rajeev B Tajhya; Christine Beeton; Martin R Jadus
Journal:  Int Immunopharmacol       Date:  2014-07-12       Impact factor: 4.932

2.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

Review 3.  Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

Authors:  Angela Poff; Andrew P Koutnik; Kathleen M Egan; Solmaz Sahebjam; Dominic D'Agostino; Nagi B Kumar
Journal:  Semin Cancer Biol       Date:  2017-12-30       Impact factor: 15.707

4.  Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.

Authors:  Giulio Zuccoli; Norina Marcello; Anna Pisanello; Franco Servadei; Salvatore Vaccaro; Purna Mukherjee; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2010-04-22       Impact factor: 4.169

5.  Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia.

Authors:  Katarína Smolková; Nadège Bellance; Francesca Scandurra; Elisabeth Génot; Erich Gnaiger; Lydie Plecitá-Hlavatá; Petr Jezek; Rodrigue Rossignol
Journal:  J Bioenerg Biomembr       Date:  2010-01-19       Impact factor: 2.945

6.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

7.  Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Jeffrey H Chuang; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-08-13       Impact factor: 5.922

8.  Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Authors:  Roy E Strowd; Mackenzie C Cervenka; Bobbie J Henry; Eric H Kossoff; Adam L Hartman; Jaishri O Blakeley
Journal:  Neurooncol Pract       Date:  2015-05-26

9.  Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.

Authors:  Gabriele D Maurer; Daniel P Brucker; Oliver Bähr; Patrick N Harter; Elke Hattingen; Stefan Walenta; Wolfgang Mueller-Klieser; Joachim P Steinbach; Johannes Rieger
Journal:  BMC Cancer       Date:  2011-07-26       Impact factor: 4.430

10.  In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2009-05-27       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.